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Dear Editor,
Acinetobacter baumannii is a cause of healthcare-associated 
infections and one of the most important pathogens found in in-
tensive care units (ICUs). The recent dramatic spread of car-
bapenem-resistant A. baumannii complex (CRAB) in Korea has 
raised substantial concern in medical practice owing to the lack 
of adequate therapeutic options [1, 2]. It is well-known that the 
selective pressure of antibiotics contributes to emergence of new 
resistant strains [3]. However, there is no sufficient evidence for 
the association between carbapenem administration and emer-
gence of imipenem-resistant A. baumannii. The rate of imipe-
nem resistance in A. baumannii isolates from general hospitals 
in Korea markedly increased from 27% in 2007 to 72% in 2010, 
according to data from a nationwide multicenter study conducted 
by the Korean Antimicrobial Resistance Monitoring System (KA-
RMS) [4], representing major public threat in Korea. In addition 
to antibiotic selection pressure, other factors could affect the 
spread of resistant organisms, such as new antimicrobial resis-
tance mechanisms, virulence, host factors, and the infection 
control policy. In this study, we aimed to elucidate the potential 
explanation for this abrupt increase in imipenem resistance in A. 
baumannii in Korea, focusing on the antibiotic selection pres-
sure nationwide.
Carbapenem is usually considered a treatment option for ex-
tended-spectrum β-lactamase (ESBL)-producing Enterobacteri-
aceae. The rate of cefotaxime resistance in Klebsiella pneumo-
niae isolates increased from 18% in 2003 to 41% in 2009, and 
that of Escherichia coli increased from 10% in 2004 to 21% in 
2008, in Korea [4]. It is mainly attributed to the spread of ESBL 
producers, which could be a main driver of carbapenem usage 
because carbapenem is the last resort for treatment of these in-
fections.
This study was approved by the National Health Insurance 
Service Ilsan Hospital Institutional Review Board, as required by 
the local hospital policy (NHIMC 2017-03-025), with permission 
from the National Health Insurance Service-National Sample 
Cohort (REQ0000007622). The antibiotic usage data in Korea 
for 12 years (from 2002 to 2013) were acquired from the Na-
tional Health Insurance Service-National Sample Cohort (NHIS-
NSC) database [5]. The systemic prescription of antibiotics based 
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on Anatomical Therapeutic Chemical (ATC) classification is stan-
dardized according to the daily defined dose (DDD) per 1000 
inhabitants [6]. The data were analyzed using SAS software ver-
sion 9.2 (SAS Institute, Cary, NC, USA). The relationship between 
antibiotic use and resistance were evaluated by simple correla-
tion analysis. The significance level was set at P <0.05.
As shown in Fig. 1, the rate of imipenem resistance in A. bau-
mannii strains isolated from general hospitals showed a good cor-
relation with the national usage data for carbapenems (including 
imipenem, meropenem, ertapenem, and total carbapenems). 
The resistance mechanism of CRAB is primarily mediated by 
Ambler’s class D OXA-type β-lactamases. Gurung et al [7] in-
vestigated the clonal diversity and genetic basis of antimicrobial 
resistance among CRAB isolates in a Korean hospital, all of which 
were found to be sequence type 2 but were classified into two 
sequence groups and nine pulso-types. blaOXA-23, which is a plas-
mid-borne gene encoding carbapenemase, was found to be 
largely responsible for resistance to carbapenems, and increased 
selection pressure of carbapenem might have facilitated the se-
lection of dominant clones. There are some limitations of this 
study. Because most CRAB strains harbor not only blaOXA-23 but 
also multidrug resistance genes such as armA, blaESBL, and 
aminoglycosides-modifying enzyme genes [8], they may be co-
selected by other classes of antibiotics that were not considered 
in this study. In addition, A. baumannii can survive for long peri-
ods in hospital settings, particularly on inanimate surfaces. Such 
environments may act as a reservoir for cross-colonization and 
infection outbreaks [9]. Although the KARMS data were collected 
from non-duplicated first isolates, the potential effect of outbreaks 
of A. baumannii infection within healthcare facilities could not 
be fully eliminated. Essentially, this represents an ecological study 
comparing groups rather than individuals, which is associated 
with some intrinsic methodological problems that limit any infer-
ence on causality [10]. Nevertheless, our data was based on 
nationwide surveillance and the antimicrobial prescription data-
base collected over a long period, which could provide useful 
information on the correlation between carbapenem administra-
tion and resistance in A. baumannii for practical applications. 
The NHIS maintains and stores all the national records for health-
care utilization and prescriptions, which could provide large-scale, 
extensive, and stable nationwide antimicrobial prescription data. 
In conclusion, a correlation between carbapenem use and re-
sistance of A. baumannii to imipenem was observed, which can 
offer insight into the increasing rate of imipenem-resistance in A. 
baumannii in Korea. These data can be used to develop national 
antibiotic usage management policies to reduce the spread of 
antibiotic resistance.
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Fig. 1. Correlation of national carbapenem usage with rate of imi-
penem resistance in Acinetobacter baumannii (IMP-R-ABA) strains 
isolated from general hospitals in Korea from 2002 to 2013. Corre-
lation of imipenem usage with IMP-R-ABA (correlation coefficient 
r=0.93, P <0.0001); correlation of meropenem usage with IMP-R-
ABA (r=0.93, P <0.0001); correlation of ertapenem usage with IMP-
R-ABA (r=0.92, P =0.0002); correlation of total carbapenem usage 
with IMP-R-ABA (r=0.94, P <0.0001).
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